Related Experiment Video
Updated: May 29, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Estrogens and prostate cancer: etiology, mediators, prevention, and management
Shuk-Mei Ho1, Ming-Tsung Lee, Hung-Ming Lam
1Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA. shuk-mei.ho@uc.edu
Abstract:
The mainstay targets for hormonal prostate cancer (PCa) therapies are based on negating androgen action. Recent epidemiologic and experimental data have pinpointed the key roles of estrogens in PCa development and progression. Racial and geographic differences, as well as age-associated changes, in estrogen synthesis and metabolism contribute significantly to the etiology. This article summarizes how different estrogens/antiestrogens/estrogen mimics contribute to prostate carcinogenesis, the roles of the different mediators of estrogen in the process, and the potentials of new estrogenic/antiestrogenic compounds for prevention and treatment of PCa.
Insights
Estrogen plays a key role in prostate cancer (PCa) development. This review explores how estrogens and related compounds influence prostate carcinogenesis and their potential for PCa prevention and treatment.
Area of Science:
- Oncology
- Endocrinology
- Urology
Background:
- Hormonal therapies for prostate cancer (PCa) primarily target androgen action.
- Emerging evidence highlights significant roles for estrogens in PCa development and progression.
- Estrogen metabolism and synthesis exhibit racial, geographic, and age-related variations influencing PCa etiology.
Purpose of the Study:
- To summarize the contribution of various estrogens, antiestrogens, and estrogen mimics to prostate carcinogenesis.
- To elucidate the roles of different estrogen mediators in PCa development.
- To explore the potential of novel estrogenic and antiestrogenic compounds for PCa prevention and treatment.
Main Methods:
- Literature review and synthesis of epidemiological and experimental data.
- Analysis of the mechanisms by which estrogens influence prostate cancer.
- Evaluation of existing and emerging estrogen-related compounds for therapeutic potential.
Main Results:
- Estrogens, antiestrogens, and estrogen mimics significantly impact prostate carcinogenesis.
- Specific mediators of estrogen action are crucial in PCa progression.
- New estrogenic/antiestrogenic compounds show promise for PCa management.
Conclusions:
- Estrogen pathways are critical targets for prostate cancer intervention.
- Understanding estrogen's role offers new avenues for PCa prevention and treatment strategies.
- Further research into estrogenic/antiestrogenic compounds could lead to novel therapies.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Mitogens and the Cell Cycle
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Menopause
Targeted Cancer Therapies
There are several types of targeted therapies against specific...